Related Experiment Videos

Plasma renin and the antihypertensive effect of 1-Sar-8-Ala-angiotensin II

D T Pals, F D Masucci

European Journal of Pharmacology

|July 1, 1973

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Appraisal of a glycopeptide cloaking strategy for a therapeutic oligopeptide: glycopeptide analogs of the renin inhibitor ditekiren.

Bioorganic & medicinal chemistry·1994

Hormonal and cardiovascular effects of losartan (DuP753), an angiotensin receptor antagonist, in nonhuman primates.

The Journal of pharmacology and experimental therapeutics·1993

Renin release induced by losartan (DuP 753), an angiotensin II receptor antagonist.

Clinical and experimental hypertension (New York, N.Y. : 1993)·1993

Conformationally constrained renin inhibitory peptides: cyclic (3-1)-1-(carboxymethyl)-L-prolyl-L-phenylalanyl-L-histidinamide as a conformational restriction at the P2-P4 tripeptide portion of the angiotensinogen template.

Journal of medicinal chemistry·1991

Renin inhibitory peptides. Incorporation of polar, hydrophilic end groups into an active renin inhibitory peptide template and their evaluation in a human renin infused rat model and in conscious sodium-depleted monkeys.

Journal of medicinal chemistry·1991

Additive combination studies of captopril and ditekiren, a renin inhibitor, in nonhuman primates.

Clinical and experimental hypertension. Part A, Theory and practice·1991

See all related articles